DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court

Share Article

http://www.DrugRisks.com is the largest resource on the web for prescription medication alerts, side effects and legal news. Visit us today.

News Image
Due to the specialized nature of federal medical device injury cases, DrugRisks only recommends lawyers and law firms who have already handled hip implant or Stryker recall lawsuits.

The hip implant safety center at DrugRisks.com is announcing new information on the site for patients who received the recalled Stryker Rejuvenate or ABG II hip systems. Stryker Orthopedics has warned investors it may face substantial litigation as patients alleging injury have asked that lawsuits be moved to a central federal court*****.

DrugRisks was designed to improve the safety of patients using popular medical devices and prescription drugs by sharing the latest warnings, recalls, studies and litigation news. Visitors can see if others are experiencing similar side effects and decide whether they need legal advice.

The resource center contains warnings from the British Medical Journal* and FDA** that toxic metal shavings from all-metal hips like the Stryker ABG II and Rejuvenate can cause serious conditions such as metallic poisoning, tissue damage, bone loss and damage to other organs.

DrugRisks has also advised patients of the Stryker hip recall of the Rejuvenate and ABG II modular implants***. The company admitted that some patients have experienced effects like adverse tissue reaction and elevated metallic blood levels, even when no symptoms are present***.

So far, more than 80 patients alleging injury from the recalled devices have filed a Stryker hip lawsuit in a New Jersey multi-district court****. Plaintiffs recently asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate the growing Stryker hip recall lawsuits to a special federal court in the U.S. District Court, District of Minnesota. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML)).

Now, DrugRisks has added information showing Stryker is advising investors that costs associated with legal claims from patients alleging injury related to the recalled hips may amount to between $190 and $390 million*****.

Anyone who received the recalled Stryker Rejuvenate or ABG II hip implant is urged to contact the DrugRisks hip center or speak with a lawyer about their full legal rights to compensation before signing anything from Stryker or Broadspire, or deciding to take action.

Due to the specialized nature of federal medical device injury cases, DrugRisks only recommends lawyers and law firms who have already handled hip implant or Stryker recall lawsuits.

Visit http://www.DrugRisks.com today for more information on the Stryker hip recall, research, side effects and litigation news, or to speak with a lawyer.

*bmj.com/content/344/bmj.e1410
**http://www.fda.gov/Medicaldevices/productsandmedicalprocedures/implantsandprosthetics/metalonmetalhipimplants/ucm241604.htm
***stryker.com/en-us/products/Orthopaedics/modularneckstems/index.htm
****northjersey.com/mahwah/Over_80_lawsuits_on_hip_implants_filed_against_Mahwah-based_Stryker_Orthopaedics_.html?page=all
*****Stryker 2012 Annual Report, Other Information, Legal and Regulatory Matters, Pg. 19; http://catalog.e-digitaleditions.com/i/114936

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website